Imatinib Inhibits GH Secretion From Somatotropinomas

about

Imatinib Inhibits GH Secretion From Somatotropinomas

Item

http://www.wikidata.org/entity/Q58633992

description

scientific article published on 27 August 2018

@en

wetenschappelijk artikel

@nl

наукова стаття, опублікована у 2018

@uk

name

Imatinib Inhibits GH Secretion From Somatotropinomas

@en

Imatinib Inhibits GH Secretion From Somatotropinomas

@nl

type

Item

label

Imatinib Inhibits GH Secretion From Somatotropinomas

@en

Imatinib Inhibits GH Secretion From Somatotropinomas

@nl

prefLabel

Imatinib Inhibits GH Secretion From Somatotropinomas

@en

Imatinib Inhibits GH Secretion From Somatotropinomas

@nl

P1476

Imatinib Inhibits GH Secretion From Somatotropinomas

@en

P2093

Anand Srinivasan

http://www.w3.org/2001/XMLSchema#string

Anil Bhansali

http://www.w3.org/2001/XMLSchema#string

Ashutosh Rai

http://www.w3.org/2001/XMLSchema#string

Bishan Das Radotra

http://www.w3.org/2001/XMLSchema#string

Debasish Hota

http://www.w3.org/2001/XMLSchema#string

Kanchan Kumar Mukherjee

http://www.w3.org/2001/XMLSchema#string

Pinaki Dutta

http://www.w3.org/2001/XMLSchema#string

Raj Pal Singh Punia

http://www.w3.org/2001/XMLSchema#string

Rakesh Kumar Vashista

http://www.w3.org/2001/XMLSchema#string

Sunil Kumar Gupta

http://www.w3.org/2001/XMLSchema#string

P2860

Vascular endothelial growth factor, its receptor KDR/Flk-1, and pituitary tumor transforming gene in pituitary tumors

The two PDGF receptors maintain conserved signaling in vivo despite divergent embryological functions

Distinct impact of imatinib on growth at prepubertal and pubertal ages of children with chronic myeloid leukemia.

VEGF-targeted therapy: mechanisms of anti-tumour activity.

Tyrosine kinase inhibitors: Multi-targeted or single-targeted?

Somatostatin analogs in treatment of non-growth hormone-secreting pituitary adenomas.

EGFR as a therapeutic target for human, canine, and mouse ACTH-secreting pituitary adenomas.

Lack of inhibitory effects of the anti-fibrotic drug imatinib on endothelial cell functions in vitro and in vivo.

Expression of AGR2 in pituitary adenomas and its association with tumor aggressiveness

Imatinib mesylate causes growth deceleration in pediatric patients with chronic myelogenous leukemia.

P304

453

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3389/FENDO.2018.00453

http://www.w3.org/2001/XMLSchema#string

P407

English

P478

http://www.w3.org/2001/XMLSchema#string

P50

Sivashanmugam Dhandapani

Naresh Sachdeva

Prakamya Gupta

P577

2018-08-27T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

30210447

http://www.w3.org/2001/XMLSchema#string

P932

6120347

http://www.w3.org/2001/XMLSchema#string